Does a truncated form of the transcription factor Ets1 exist in breast cancer cells?

British Journal of Cancer

Volumn 94, Issue 1, 2006, Pages 176-177

  Dittmer, J ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; PROTEIN; PROTEIN P33; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL; CANCER INVASION; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

ANNEXIN A5; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TUMOR CELLS, CULTURED;

EID: 30644465658     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602903     Document Type: Letter

References (11)

1. Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O'Higgins N, Duffy MJ (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer 91: 1308-1315
2. Dittmer J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29
3. Dubois T, Mira JP, Feliers D, Solito E, Russo-Marie F, Oudinet JP (1998) Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J 330(Part 3): 1277-1282
4. Foos G, Hauser C (2004) The role of Ets transcription factors in mediating cellular transformation. In Handbook of Experimental Pharmacology Gossen M, Kaufmann J, Triezenberg SJ (eds), vol. 166, pp. 259-275. Springer: Heidelberg
5. Hsu T, Trojanowska M, Watson DK (2004) Ets proteins in biological control and cancer. J Cell Biochem 91: 896-903
6. Jonsen MD, Petersen JM, Xu QP, Graves BJ (1996) Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol 16: 2065-2073
7. Jorcyk CL, Watson DK, Mavrothalassitis GJ, Papas TS (1991) The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene 6: 523-532
8. Lindemann RK, Ballschmieter P, Nordheim A, Dittmer J (2001) Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J Biol Chem 276: 46661-46670
9. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV, Sweep CG (2002) Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21: 8506-8509
10. Sun J, Salem HH, Bird P (1992) Nucleolar and cytoplasmic localization of annexin V. FEBS Lett 314: 425-429
11. Vetter M, Blumenthal SG, Lindemann RK, Manns J, Wesselborg S, Thomssen C, Dittmer J (2005) Ets1 is an effector of protein kinase Calpha in cancer cells. Oncogene 24: 650-661